Skip to contentC
Cerenome, Inc.
C
CNSYCerenome, Inc. Q1 2025 · 10-Q
Revenue$1.06M$1.06M−36.9% vs Q1 2024 Net Income-$17.40M-$17.40MN/M vs Q1 2024 EPS Diluted-$29.86-$29.86N/M vs Q1 2024 Operating Income-$3,536,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cerenome, Inc. · CIK 1095981 · Engraved from SEC EDGAR
Free Cash Flowderived-$6,175,000N/M Margins · derivedOperating margin-333.9%−137.2 pt vs Q1 2024
Net margin-1643.2%−1448.7 pt vs Q1 2024
ended Mar 31, 2025 · filed May 30, 2025 · 60 d after period end